Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05072093 · ClinicalTrials.gov registry record · Phase 4
Parrying the Pitfalls of PrEP: Project PEACH
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 240
- Enrollment target
NCT05072093 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 240 participants.
The verdict
NCT05072093, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 240 participants
- Enrollment target
Study Summary
The study is a prospective cohort of young MSM who are followed for 2 years either in-person at the PRISM Health Research Clinic and/or virtually with telehealth study visits. Follow-up visits occur as frequently as every 3 months, or as appropriate to clinical needs of HIV PrEP or STI PEP. The investigators will enroll men who may decide to start or stop PrEP, change from daily oral PrEP to on-demand oral PrEP or from on-demand oral PrEP to daily PrEP, to start or stop STI PEP at any point in the study period, or injectable PrEP as an alternative to daily oral PrEP or on-demand oral PrEP. All men will be provided with the study's mobile smart phone app to support early identification of risks for PrEP discontinuation, to provide information about STI PEP and document usage patterns of on-demand oral PrEP and STI PEP, and to support easy linkage to support services for PrEP counseling and addressing concerns or questions about STI PEP and injectable PrEP.
Interventions
- BEHAVIORAL PrEP discontinuation intervention
- DRUG Offering of on-demand oral PrEP
- DRUG Offering of STI PEP
- DRUG Injectable PrEP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2021-11-20 |
| Est. Completion | 2025-03-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05072093
The ClinicalTrials.gov registry entry for NCT05072093 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which PrEP discontinuation intervention is the first listed.
NCT05072093 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05072093 about?
NCT05072093 is a clinical study titled "Parrying the Pitfalls of PrEP: Project PEACH". The study is a prospective cohort of young MSM who are followed for 2 years either in-person at the PRISM Health Research Clinic and/or virtually with telehealth study visits. Follow-up visits occur as frequently as every 3 months, or as appropriate to clinical needs of HIV PrEP or STI PEP. The inve...
What is the current status of trial NCT05072093?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 240 participants. The study started on 2021-11-20. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT05072093?
The interventions under investigation include: PrEP discontinuation intervention (BEHAVIORAL), Offering of on-demand oral PrEP (DRUG), Offering of STI PEP (DRUG), Injectable PrEP (DRUG).
Who is sponsoring clinical trial NCT05072093?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.